NCT06518005 Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome Status RECRUITING Phase PHASE2
NCT06461546 Imlifidase in Living Donor Renal Transplantation Highly Sensitized Recipients Status WITHDRAWN Phase PHASE2
NCT06241950 A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74) Status TERMINATED Phase PHASE1
NCT05753930 Imlifidase Prior to Kidney Transplant in Highly Sensitised Children Status RECRUITING Phase PHASE2
NCT05369975 Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts Status COMPLETED Phase PHASE3
NCT05049850 A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation Status TERMINATED Phase PHASE2
NCT04935177 Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx Status COMPLETED Phase PHASE3
NCT04711850 An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR Status TERMINATED Phase N/A
NCT03943589 A Study of Imlifidase in Patients With Guillain-Barré Syndrome Status COMPLETED Phase PHASE2
NCT03897205 An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients Status COMPLETED Phase PHASE2
NCT03611621 A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation Status COMPLETED Phase N/A
NCT03157037 Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease Status COMPLETED Phase PHASE2